NCT02052349View on ClinicalTrials.gov

Bioavailability of ABT-333 Within the Gastrointestinal Tract in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Relative Bioavailability

Interventions

DRUG

ABT-333

Dose of ABT-333

Trial Locations (1)

NG11 6JS

Site Reference ID/Investigator# 118435, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AbbVie

INDUSTRY